Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 14, 2009; 15(30): 3713-3724
Published online Aug 14, 2009. doi: 10.3748/wjg.15.3713
Published online Aug 14, 2009. doi: 10.3748/wjg.15.3713
Table 3 Barriers against anti-HCV therapy in co-infected patients
| Patient-related factors |
| Active substance abuse |
| Concern regarding adverse effects |
| Cost of treatment |
| Lack of social support |
| Lack of transport |
| Number of pills and dosing frequency (including HAART) |
| Physician-related factors |
| Lack of experience |
| Lack of awareness |
| Lack of motivation for referral |
| Fear of adverse effects |
- Citation: Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 2009; 15(30): 3713-3724
- URL: https://www.wjgnet.com/1007-9327/full/v15/i30/3713.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3713